JUN 03, 2019 02:43 PM PDT

Manuka Honey Kills Cystic Fibrosis Pathogens in Culture

WRITTEN BY: Carmen Leitch

Honey is recognized as a natural antimicrobial agent, and has been used in folk medicines for thousands of years. It may help us as we face the rising threat of antibiotic-resistant microbes. Now researchers at Swansea University have found that Manuka honey (which has a bigger antimicrobial effect than regular honey) can destroy bacteria that are associated with lung infections often seen in cystic fibrosis (CF) patients. The findings, which may offer a natural way to combat CF-related lung infections, have been reported in Frontiers in Microbiology.

Honey / Credit: Pexels

"The preliminary results are very promising and should these be replicated in the clinical setting then this could open up additional treatment options for those with cystic fibrosis infections," said the senior study author, Dr. Rowena Jenkins, a Lecturer in Microbiology and Infectious Diseases at Swansea University.

In this work, the researchers treated pig lung tissue that modeled the lung infections seen in CF with Manuka honey. The honey killed 39 percent of antibiotic-resistant bacteria, while tissue treated with antibiotics killed only 29 percent of the bacteria. When Manuka honey was used in combination with antibiotics, 90 percent of the infectious bacteria were eliminated.

Cystic fibrosis is a genetic disorder in which the airways become clogged with mucus, and prone to chronic infection. Many of those lung infections will be fatal because they can’t be effectively treated; drug-resistant microbes are often to blame. A lung transplant may be an option for some patients when the bacteria can’t be removed, but the pathogens can still hang out in the upper airway and cause another infection in newly transplanted lungs. 

As many as 80 percent of CF patients will develop a Pseudomonas aeruginosa infection, making effective treatment essential to the management of the disorder. Antibiotics may not always be able to kill the microbes causing the infection, so finding alternatives is critical. This work may help researchers and clinicians develop a good alternative.

One major challenge in the development of honey as a therapeutic for lung infections is delivering it. Getting honey into the lungs poses major challenges. The researchers acknowledged that converting antimicrobials into an inhalable spray is inefficient and problematic. High concentrations of the honey might have a detrimental effect on some human cells in the lungs. However, right now it can be easily made into a sinus rinse, the scientists noted, and prevent the movement of the infections microbes from the lungs to the sinuses.

“The synergy with antibiotics and absence of resistance seen in the laboratory has allowed us to move into the current clinical trial, investigating the potential for Manuka honey as part of a sinus rinse for alleviating infection in the upper airway," added Jenkins.


Sources: AAAS/Eurekalert! via Swansea University, Frontiers in Microbiology 

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 17, 2020
Microbiology
JAN 17, 2020
Molecule in Human Breast Milk Can Fight Microbial Pathogens
Now a team of scientists has found a molecule in human breast milk that may reduce the risk of illness and disease....
JAN 17, 2020
Microbiology
JAN 17, 2020
Complex Symbiotic Relationship Between Bees and Fungi is Revealed
An international team of researchers has learned more about how a stingless bee relies on several different fungi to survive....
JAN 17, 2020
Microbiology
JAN 17, 2020
The Rare Syndrome That Causes People to Produce Alcohol in Their Gut
Some people are affected by a syndrome in which their gut microbes generate enough alcohol to cause symptoms of intoxication....
JAN 17, 2020
Microbiology
JAN 17, 2020
The Mechanism of Lysostaphin, a MRSA-Killing Enzyme, is Revealed
This study can help inform the development of new treatments for antibiotic-resistant microbes....
JAN 17, 2020
Microbiology
JAN 17, 2020
Probiotics Linked to Bloodstream Infections in ICU Patients
Probiotics, which are live microbes, are intended to improve human health, and they are sometimes given to intensive care unit patients of all ages....
JAN 17, 2020
Genetics & Genomics
JAN 17, 2020
Researchers Rewire E. coli to Consume Carbon Dioxide
Milo et. al.   Researchers have genetically rewired the metabolism of Escherichia coli to be autotrophic, using formate (COOH) as a food sou...
Loading Comments...